Royalty Pharma EPS Diluted (Quarterly) Trends

Royalty Pharma PLC (RPRX)

25.80 +0.10 (+0.37%) USD | NASDAQ | Nov 18, 16:00

25.80 0.00 (0.00%) After-Hours: 20:00

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
September 30, 2024	1.21
June 30, 2024	0.23
March 31, 2024	0.01
December 31, 2023	1.10
September 30, 2023	0.16
June 30, 2023	0.50
March 31, 2023	0.76
December 31, 2022	-1.468
September 30, 2022	0.32
June 30, 2022	0.70
March 31, 2022	0.12
December 31, 2021	-0.661

Date	Value
September 30, 2021	0.24
June 30, 2021	1.08
March 31, 2021	0.18
December 31, 2020	0.4406
September 30, 2020	0.79
June 30, 2020	0.09
March 31, 2020	0.2032
December 31, 2019	4.010
September 30, 2019	1.155
June 30, 2019	0.4284
March 31, 2019	1.038

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-1.468

Minimum

Dec 2022

4.010

Maximum

Dec 2019

0.5008

Average

0.28

Median

EPS Diluted (Quarterly) Benchmarks

Geron Corp	-0.04
Amicus Therapeutics Inc	-0.02
Ionis Pharmaceuticals Inc	-0.95
Arbutus Biopharma Corp	-0.10
Syndax Pharmaceuticals Inc	-0.98

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly)	543.99M
Revenue (Quarterly)	564.69M
Total Expenses (Quarterly)	-170.38M
Enterprise Value	20.65B
Profit Margin (Quarterly)	96.33%
Earnings Yield	9.89%
Operating Earnings Yield	10.04%
Normalized Earnings Yield	7.597